Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
9.03
-0.24 (-2.59%)
Jul 3, 2025, 1:00 PM EDT - Market closed
Sensei Biotherapeutics Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$86.67
Upside
+859.80%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +1,007.42% | Jun 2, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $70 → $80 | Buy | Maintains | $70 → $80 | +785.94% | Mar 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +785.94% | Mar 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +785.94% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $80 | Strong Buy | Maintains | $80 | +785.94% | Jan 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +785.94% | Aug 7, 2024 |
| Citigroup | Citigroup | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +785.94% | Jun 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +785.94% | May 24, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $100 | Buy | Reiterates | $100 | +1,007.42% | May 24, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $100 | Buy | Initiates | $100 | +1,007.42% | May 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +785.94% | Dec 4, 2023 |
| Citigroup | Citigroup | Strong Buy Initiates $120 | Strong Buy | Initiates | $120 | +1,228.90% | Dec 13, 2022 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $100 | Hold → Buy | Upgrades | $100 | +1,007.42% | Oct 3, 2022 |
| Piper Sandler | Piper Sandler | Buy Maintains $240 → $200 | Buy | Maintains | $240 → $200 | +2,114.84% | Mar 10, 2022 |
| Berenberg | Berenberg | Strong Buy → Hold Downgrades $240 | Strong Buy → Hold | Downgrades | $240 | +2,557.81% | Jul 1, 2021 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jun 29, 2021 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.